10.85
price up icon8.56%   0.855
after-market Handel nachbörslich: 10.85 0.005 +0.05%
loading
Schlusskurs vom Vortag:
$9.99
Offen:
$9.95
24-Stunden-Volumen:
331.33K
Relative Volume:
2.10
Marktkapitalisierung:
$227.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.48%
1M Leistung:
+49.59%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$9.85
$11.19
1-Wochen-Bereich:
Value
$8.61
$11.19
52-Wochen-Spanne:
Value
$6.565
$13.47

Jade Biosciences Inc Stock (JBIO) Company Profile

Name
Firmenname
Jade Biosciences Inc
Name
Telefon
617-443-2400
Name
Adresse
930 WINTER STREET, WALTHAM
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-19
Name
Neueste SEC-Einreichungen
Name
JBIO's Discussions on Twitter

Vergleichen Sie JBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
JBIO
Jade Biosciences Inc
10.85 227.59M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-16 Hochstufung Guggenheim Neutral → Buy
2025-05-07 Eingeleitet Wedbush Outperform
2025-05-05 Eingeleitet Stifel Buy
2025-05-02 Eingeleitet TD Cowen Buy
2024-06-18 Herabstufung Evercore ISI Outperform → In-line
2024-06-18 Herabstufung TD Cowen Buy → Hold
2024-06-18 Herabstufung Wells Fargo Overweight → Equal Weight
2024-06-17 Herabstufung BTIG Research Buy → Neutral
2024-06-17 Herabstufung Guggenheim Buy → Neutral
2024-06-17 Herabstufung Wedbush Outperform → Neutral
2024-03-25 Fortgesetzt Jefferies Buy
2023-12-08 Eingeleitet Wells Fargo Equal Weight
2023-03-01 Eingeleitet Guggenheim Buy
2022-12-06 Hochstufung BTIG Research Neutral → Buy
2022-09-19 Fortgesetzt Wedbush Outperform
2022-08-16 Herabstufung BTIG Research Buy → Neutral
2022-02-11 Eingeleitet BTIG Research Buy
2021-07-26 Eingeleitet Cowen Outperform
2021-07-26 Eingeleitet Evercore ISI Outperform
2021-07-26 Eingeleitet Jefferies Buy
2021-07-26 Eingeleitet Wedbush Outperform
Alle ansehen

Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten

pulisher
Jun 16, 2025

Guggenheim Upgrades Jade Biosciences to Buy From Neutral, Price Target is $14 - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Guggenheim upgrades Jade Biosciences stock rating to Buy on transformation - Investing.com Canada

Jun 16, 2025
pulisher
Jun 13, 2025

JADE-101 ameliorates IgA nephropathy features in preclinical setting - BioWorld MedTech

Jun 13, 2025
pulisher
Jun 09, 2025

Jade Biosciences Presents JADE101 Preclinical Data at the - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

New IgA Nephropathy Drug Shows 750x Better Binding: JADE101 Outperforms Competitors in Key Metrics - Stock Titan

Jun 09, 2025
pulisher
Jun 02, 2025

Jade Biosciences Announces Presentation of Preclinical Data on JADE101 at 62nd European Renal Association Congress - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Breakthrough IgA Nephropathy Treatment: Jade Biosciences Reveals New JADE101 Antibody Data at ERA Congress - Stock Titan

Jun 02, 2025
pulisher
May 20, 2025

Insider Buying: CEO Tom Frohlich Acquires Shares in Jade Bioscie - GuruFocus

May 20, 2025
pulisher
May 14, 2025

JBIOJade Biosciences Inc Latest Stock News & Market Updates - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Jade Biosciences, Inc. Completes Reverse Merger, Launches Nasdaq Trading as JBIO, and Secures $300 Million Financing - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Jade Biosciences Secures Massive $300M Funding After Nasdaq Debut, First Clinical Trial Set for 2025 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 13, 2025
pulisher
May 05, 2025

Stifel Nicolaus Initiates Coverage on Jade Biosciences With Buy Rating, $19 Price Target - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Stifel initiates Jade Biosciences stock with a Buy, $19 target - Investing.com

May 05, 2025
pulisher
May 05, 2025

Stifel initiates Jade Biosciences stock with a Buy, $19 target By Investing.com - Investing.com India

May 05, 2025
pulisher
May 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - marketscreener.com

May 03, 2025
pulisher
May 03, 2025

Aerovate Therapeutics, Inc. Announces Board Changes - marketscreener.com

May 03, 2025
pulisher
May 02, 2025

TD Cowen starts Jade Biosciences coverage with Buy rating By Investing.com - Investing.com Nigeria

May 02, 2025
pulisher
May 02, 2025

TD Cowen Initiates Coverage on Jade Biosciences With Buy Rating - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TD Cowen starts Jade Biosciences coverage with Buy rating - Investing.com

May 02, 2025
pulisher
May 01, 2025

Aerovate Therapeutics Completes Merger with Jade Biosciences - TipRanks

May 01, 2025
pulisher
May 01, 2025

Aerovate Therapeutics Announces Range of Expected Cash Dividend - marketscreener.com

May 01, 2025
pulisher
Apr 30, 2025

RTW Biotech Opportunities’ Jade Biosciences merges with Aerovate Therapeutics - QuotedData

Apr 30, 2025
pulisher
Apr 29, 2025

JBIO Stock Price and Chart — NASDAQ:JBIO - TradingView

Apr 29, 2025
pulisher
Apr 29, 2025

Jade Biosciences Highlights JADE-001 Progress in Presentation - TipRanks

Apr 29, 2025
pulisher
Apr 28, 2025

Jade Biosciences closes merger with Aerovate Therapeutics - Business in Vancouver

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously ... - Bluefield Daily Telegraph

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate - GlobeNewswire

Apr 28, 2025
pulisher
Apr 25, 2025

Aerovate Therapeutics, Inc. SEC 10-Q Report - TradingView

Apr 25, 2025
pulisher
Apr 24, 2025

Aerovate Therapeutics (AVTE) Declares Special Dividend Amid Merg - GuruFocus

Apr 24, 2025
pulisher
Apr 21, 2025

Aerovate Therapeutics stockholders approve proposed merger with Jade Biosciences - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Aerovate approves reverse split ahead of Jade merger - Investing.com

Apr 21, 2025
pulisher
Apr 09, 2025

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - The Malaysian Reserve

Apr 09, 2025
pulisher
Apr 07, 2025

Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire

Apr 07, 2025
pulisher
Mar 27, 2025

Aerovate Therapeutics Inc. (AVTE) reports earnings - qz.com

Mar 27, 2025
pulisher
Mar 21, 2025

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire

Mar 21, 2025
pulisher
Feb 28, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 24, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders - The Malaysian Reserve

Feb 24, 2025
pulisher
Feb 12, 2025

Jade Biosciences to Participate in TD Cowen’s 45th Annual - GlobeNewswire

Feb 12, 2025
pulisher
Feb 06, 2025

Jade Biosciences, Inc. to Present New Preclinical Data on Jade101 At the 62nd European Renal Association Congress - marketscreener.com

Feb 06, 2025
pulisher
Jan 23, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerIPG, VTS, AVTE, MHLD - The Victoria Advocate

Jan 23, 2025
pulisher
Dec 28, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Dec 28, 2024
pulisher
Dec 19, 2024

Borealis Biosciences Appoints Christian Hordo as CEO and Expands Series A Financing - Business Wire

Dec 19, 2024
pulisher
Nov 13, 2024

Jade Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 13, 2024
pulisher
Nov 01, 2024

How Fairmount’s Paragon incubator steered two more companies to NASDAQ - biocentury.com

Nov 01, 2024
pulisher
Oct 31, 2024

Paragon spinout Jade casts reverse merger spell with Aerovate - Fierce Biotech

Oct 31, 2024
pulisher
Oct 29, 2024

Paragon launches another company in hot PD-1xVEGF space that goes straight to reverse merger - Endpoints News

Oct 29, 2024
pulisher
Oct 25, 2024

Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson - Endpoints News

Oct 25, 2024

Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)

Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):